OS Therapies Inc

OSTX · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 5 employees
58
SEC Filings
$1.87
Close 2026-06-01
5
Employees

Business Summary

. Overview and Mission OS Therapies Incorporated (OS Therapies, the Company, we, our or us) is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults. Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to i...

Latest Stock Quote

OSTX 2026-06-01 $1.87 O:$2.14 H:$2.1986 L:$1.83 Vol:1.8M VWAP:$1.9671
origin leaf: 0ce8cf40858350020cf902b9fa83ec61c77de4e916b39cbbc3e8fbdaf368f53a

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001213900-26-036629EDGAR80K words
2025-03-312024-12-310001213900-25-026238EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001213900-25-110829EDGAR33K words
2025-08-182025-06-300001213900-25-077916EDGAR—
2025-05-152025-03-310001213900-25-044336EDGAR—
2024-11-152024-09-300001213900-24-098760EDGAR—
2024-08-142024-06-300001213900-24-069063EDGAR—
2024-05-202024-03-310001213900-24-045141EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001213900-26-039529EDGAR23K words
2026-03-310001213900-26-037476EDGAR—
2026-03-060001213900-26-024726EDGAR—
2026-02-130001213900-26-016408EDGAR—
2026-01-120001213900-26-003166EDGAR—
2025-10-210001213900-25-100821EDGAR—
2025-10-170001213900-25-100019EDGAR—
2025-09-300001213900-25-093936EDGAR—
2025-09-020001213900-25-083396EDGAR—
2025-08-260001213900-25-080484EDGAR—

58 total filings indexed. 40 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001795091
TickerOSTX
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.ostherapies.com
Listed2024-08-01

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 682bd77f77587bf48f30142d2b502911201a25782438a91eb8c884031bae4962
parent: 75f63ab2a9aec705f4523b0d65d3e4163278ecc95e0e2d430d53ecfa628df419
content hash: dcd47d539b5d1c00cf9508947bf6b1582be677e092fca3c3a782cf88c362d60b
signed: 2026-06-02T19:02:12.423Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf